Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response
Abstract Backgrounds Since breast cancer patients respond diversely to immunotherapy, there is an urgent need to explore novel biomarkers to precisely predict clinical responses and enhance therapeutic efficacy. The purpose of our present research was to construct and independently validate a biomar...
Main Authors: | Xiaorui Han, Yuan Guo, Huifen Ye, Zhihong Chen, Qingru Hu, Xinhua Wei, Zaiyi Liu, Changhong Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Breast Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13058-024-01776-y |
Similar Items
-
Identification of Crucial Gene Modules Related to the Efficiency of Anti-PD-1/PD-L1 Therapy and Comprehensive Analyses of a Novel Signature Based on These Modules
by: Wei Wang, et al.
Published: (2022-07-01) -
Radiomics Assessment of the Tumor Immune Microenvironment to Predict Outcomes in Breast Cancer
by: Xiaorui Han, et al.
Published: (2022-01-01) -
Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC
by: Amine Bouhamama, et al.
Published: (2023-05-01) -
Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection
by: Pinxiong Li, et al.
Published: (2021-08-01) -
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
by: Takuro Shiiba, et al.
Published: (2022-06-01)